Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Endocrine-Related Cancer|March 15, 2015
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinomaJ Hadoux, D Malka, D Planchard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2015
Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIVF A Lévi, V Boige, M Hebbar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 10, 2024
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trialT Conroy, F Castan, P-L Etienne, et al.
The Pharmacogenomics Journal|April 9, 2014
The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysisM M Dias, J-P Pignon, C S Karapetis, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 22, 2026
Dihydropyrimidine dehydrogenase phenotype-guided dose individualization of fluoropyrimidine in gastrointestinal cancers: PRODIGE100-UCGI48-FUDOSE phase II studyG M Camilleri, M A Loriot, G Le Teuff, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Codon-specific KRAS mutations predict survival in advanced pancreatic cancerA Boilève, A Rousseau, M Hilmi, et al.
Digestive Diseases and Sciences|October 31, 2022
The Frequency of Germline BRCA and Non-BRCA HR-Gene-Variants in a Cohort of Pancreatic Cancer PatientsM Baz, V Gondran-Teiller, B Bressac, et al.
Pageof 8